Which is the most dominant region for the United Kingdom AI Diagnostics and Community Diagnostic Centres Market?

England is the most dominant region in the United Kingdom AI Diagnostics and Community Diagnostic Centres Market, supported by extensive deployment of Community Diagnostic Centres, high diagnostic testing volumes, strong healthcare infrastructure, and widespread adoption of AI-enabled diagnostic technologies across NHS networks. Scotland is expected to be the fastest-growing region during the forecast period of 2026–2030, driven by increasing investments in healthcare digitalization, diagnostic modernization initiatives, and broader adoption of AI-supported clinical workflows. Wales and Northern Ireland continue to experience steady growth supported by ongoing healthcare transformation programs and expanding diagnostic capabilities.

Which Companies are key players in the United Kingdom AI Diagnostics and Community Diagnostic Centres Market?

The key players in the United Kingdom AI Diagnostics and Community Diagnostic Centres Market include Siemens Healthineers, Philips Healthcare, GE HealthCare, InHealth Group, Alliance Medical, Medica Group, Sectra, Brainomix, Kheiron Medical Technologies, Skin Analytics, Qure.ai, Paige, Lunit, Annalise.ai, and Oxford Nanopore Technologies.

United Kingdom AI Diagnostics and Community Diagnostic Centres Market | Size, Overview, Trends & Forecast 2026

Q: What is the size of the United Kingdom AI Diagnostics and Community Diagnostic Centres Market?

The United Kingdom AI Diagnostics and Community Diagnostic Centres Market was valued at approximately USD 318.7 Million. It is projected to grow at a CAGR of around 24.2% during the forecast period of 2026–2030, reaching an estimated USD 941.87 Million by 2030.

Q: What are the United Kingdom AI Diagnostics and Community Diagnostic Centres Market Drivers?

The major drivers of the United Kingdom AI Diagnostics and Community Diagnostic Centres Market include increasing demand for efficiency in diagnostic processes across healthcare settings, expansion of digital healthcare infrastructure, and growing emphasis on earlier disease detection through automated analysis. Healthcare providers are increasingly adopting AI-enabled diagnostic solutions to improve workflow efficiency, reduce reporting burdens, enhance diagnostic accuracy, and optimize resource utilization. Furthermore, investments in interoperability, cloud-enabled healthcare systems, connected clinical platforms, and diagnostic modernization initiatives are accelerating market adoption across Community Diagnostic Centres and broader NHS diagnostic networks.

United Kingdom AI Diagnostics and Community Diagnostic Centres Market Research Report – Segmented by Diagnostic Modality (Imaging AI Diagnostics, Pathology & Laboratory AI Diagnostics, Cardiology AI Diagnostics, Respiratory AI Diagnostics, Ophthalmology AI Diagnostics, Neurology AI Diagnostics, Others); by Deployment Environment (Community Diagnostic Centres (CDCs), NHS Acute Hospital Diagnostic Hubs, Primary Care Diagnostic Networks, Independent Diagnostic Centres, Mobile & Outreach Diagnostic Units, Others); by Technology Type (Computer Vision AI, Machine Learning & Predictive Analytics, Natural Language Processing, Clinical Decision Support AI, Generative AI for Diagnostic Workflow, Others); by Clinical Care Pathway (Cancer Diagnostics, Cardiovascular Diagnostics, Respiratory Diagnostics, Neurological Diagnostics, Musculoskeletal Diagnostics, Women's Health Diagnostics, General Preventive & Screening Diagnostics, Others); by Revenue Model (Software Licensing, Software-as-a-Service (SaaS), Per-Scan/Per-Test Usage Fees, Managed Diagnostic Services, Outcome-Based & Value-Based Contracts, Others) ; and Region - Size, Share, Growth Analysis | Forecast (2026– 2030)

Published: 2026 - Jun

Report Code: VMR-19426

Region: Europe

Historic Range: 2023-2025

Forecast: 2026-2032

Format: Excel and PDF

👨‍💼 Ask an Expert

Fill out the form below and our team will get back to you shortly

The field with (*) is required.

📋 Contact Information

Name *

Email *

Company *

Job Title *

Country *

Phone *

Message (Optional)

Security Verification

This form is protected by Google reCAPTCHA v3. Verification runs automatically when you submit.

Your information is secure and will not be shared with third parties.

Select User License Type

Data Spreadsheet: Market data delivered in spreadsheet format for analysis.

Single User: One named user; PDF report access for internal use.

Multi User: Up to five users within the same organization at one location.

Corporate User: Enterprise-wide access across your organization.

Data Spreadsheet

2500

Single User

3400

Multi User

3900

Corporate User

4600

Country-Specific Report

Dive into Country Outlook

Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.

Access Country Insights

Testimonials

“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”

Medical Devices Company based in Europe